These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33859934)

  • 1. Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status.
    Akce M; Zakka K; Jiang R; Williamson S; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
    Front Oncol; 2021; 11():592351. PubMed ID: 33859934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial.
    Klingbiel D; Saridaki Z; Roth AD; Bosman FT; Delorenzi M; Tejpar S
    Ann Oncol; 2015 Jan; 26(1):126-132. PubMed ID: 25361982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
    Shaib WL; Zakka KM; Jiang R; Yan M; Alese OB; Akce M; Wu C; Behera M; El-Rayes BF
    Cancer; 2020 Sep; 126(18):4136-4147. PubMed ID: 32697360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
    JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
    Koenig JL; Toesca DAS; Harris JP; Tsai CJ; Haraldsdottir S; Lin AY; Pollom EL; Chang DT
    Am J Clin Oncol; 2019 Jul; 42(7):573-580. PubMed ID: 31166206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer.
    Kim ST; Lee SJ; Lee J; Park SH; Park JO; Lim HY; Kang WK; Park YS
    J Cancer; 2017; 8(14):2809-2815. PubMed ID: 28928870
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.
    Qin Q; Yang L; Sun YK; Ying JM; Song Y; Zhang W; Wang JW; Zhou AP
    Chronic Dis Transl Med; 2017 Mar; 3(1):51-59. PubMed ID: 29063056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
    Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
    Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer.
    Mohamed A; Jiang R; Philip PA; Diab M; Behera M; Wu C; Alese O; Shaib WL; Gaines TM; Balch GG; El-Rayes BF; Akce M
    Front Oncol; 2021; 11():755113. PubMed ID: 34760701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.
    Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA
    Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?
    Zakka K; Williamson S; Jiang R; Reid MD; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF; Akce M
    Surg Oncol; 2021 Mar; 36():120-129. PubMed ID: 33360118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between microsatellite instability and clinico-pathological characteristics in sporadic colon cancer].
    Guerrero D; Balen E; Martínez-Peñuela JM; García-Foncillas J; Larrinaga B; Caballero MC; Herrera J; Lera JM
    Med Clin (Barc); 2005 Apr; 124(12):441-6. PubMed ID: 15826579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
    Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
    Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer.
    Oh SY; Kim DY; Kim YB; Suh KW
    World J Surg; 2013 Oct; 37(10):2497-503. PubMed ID: 23754140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
    Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
    Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Impact of Microsatellite Instability on the Outcome of Appendiceal Adenocarcinoma: a National Cancer Database Analysis.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
    J Gastrointest Surg; 2023 Feb; 27(2):354-362. PubMed ID: 36650414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of molecular profile on the lymphatic spread pattern in stage III colon cancer.
    Song J; Kataoka K; Yamada T; Shiozawa M; Sonoyama T; Beppu N; Ueda K; Kuriyama S; Kanazawa A; Ikeda M; Ceelen W
    Cancer Sci; 2021 Apr; 112(4):1545-1555. PubMed ID: 33484192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage.
    Bläker H; Alwers E; Arnold A; Herpel E; Tagscherer KE; Roth W; Jansen L; Walter V; Kloor M; Chang-Claude J; Brenner H; Hoffmeister M
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):455-462.e6. PubMed ID: 29660527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.